PRECLINICAL AND HUMAN CORRELATIVE STUDIES OF A NOVEL BRUTON TYROSINE KINASE INHIBITOR IN PANCREATIC CANCER
$500,237FY2016Department of the ArmyDOD
The Univeristy Of Texas M.D. Anderson Cancer Center
The Univeristy Of Texas M.D. Anderson Cancer Center